« Previous
Next »
Journal of Affective Disorders
Volume 91, Issue 1
, Pages 83-86
, March 2006
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients
References
- . Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 2004;24:2667–2677
- . BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry. 2005;10:345–352
- . The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2005;29:261–265
- . Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol. 2004;4:58–64
- . Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004;5:11–25
- . Transcranial magnetic stimulation. Neurosurg. Clin. N. Am. 2003;14:283–301
- Gonul, A.S., Akdeniz, F., Taneli, F., Donat, O., Eker, C., Vahip, S., 2005. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci. Published online April 2005
- . Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004;45:104–114
- . Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002;109:143–148
- . Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002;328:261–264
- . Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry. 2005;57:1068–1072
- . Applications of TMS to therapy in psychiatry. J. Clin. Neurophysiol. 2002;19:344–360
- . The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging. 2005;26:115–123
- . Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency: an efficacious therapy for major drug-resistant depression?. Clin. Neurophysiol. 2005;116:1062–1071
- . Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 2000;23:205–215
- . Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am. J. Psychiatry. 2005;162:805–807
- . Repetitive transcranial magnetic stimulation: does it have potential in the treatment of depression?. CNS Drugs. 2003;17:383–403
- . Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37:1553–1561
- . Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 1996;709:122–301
- Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr. Clin. Neurophysiol. 1994;91:79–92
- . Brain-derived neurotrophic factor and antidepressant activity. Curr. Pharm. Des. 2005;11:1495–1510
- . Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J. Neurosci. 2003;23:349–357
- . Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 2005;25:1089–1094
- . Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry. 2003;54:70–75
- . Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5–7, 1996. Electroencephalogr. Clin. Neurophysiol. 1998;108:1–16
PII: S0165-0327(05)00416-7
doi: 10.1016/j.jad.2005.12.029
© 2005 Elsevier B.V. All rights reserved.
« Previous
Next »
Journal of Affective Disorders
Volume 91, Issue 1
, Pages 83-86
, March 2006
